# CHV Capital

CHV Capital is a Venture Capital based in Indianapolis, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Indianapolis, United States
- **Region:** North America
- **Address:** Indianapolis, IN, United States
- **Founded:** 2008
- **Assets under management:** Undisclosed
- **Website:** chvcapital.com
- **LinkedIn:** https://www.linkedin.com/company/chv-vc

## Regulatory record

- **Reports private funds:** No

## About

CHV Capital is an early-stage investor focused on business opportunities serving a business or clinical need. The company provides venture capital guided by Indiana University Health's strategic objectives. CHV Capital has made 28 investments, including a Series A - II investment in Springbuk on June 28, 2017.

## Sectors

- Digital Health
- Healthcare Services
- Enterprise Software

## Questions

### Does CHV Capital invest only in Indiana-based companies?

No. While CHV Capital is rooted in the Indiana life-sciences ecosystem and has close ties to regional research institutions, the firm invests nationally in health-technology companies that can derive strategic value from a relationship with IU Health's clinical and operational infrastructure. Portfolio company pilots and clinical validation studies frequently occur inside IU Health facilities regardless of the company's headquarters.

### How does being tied to an academic medical center affect CHV Capital's investment approach?

The IU Health affiliation gives CHV Capital a distinctive due-diligence and value-creation capability: companies can be evaluated by practicing clinicians, tested in real patient-care settings, and introduced to a concentrated base of potential enterprise customers. This clinical-integration model is rare among early-stage health-tech investors and functions as CHV Capital's primary sourcing and selection moat.

### What investment stages does CHV Capital target?

The firm focuses primarily on early-stage companies — seed through Series B — with an emphasis on opportunities where clinical validation and health-system adoption are the next critical milestones. This aligns with the point at which IU Health's clinical-testing infrastructure provides the greatest strategic advantage.

## Related profiles

- [Chunxin Capital](https://altss.com/profile/chunxin-capital)
- [Circle Capital Ventures](https://altss.com/profile/circle-capital-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/chv-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology